Open AccessEuglycemic diabetic ketoacidosis in pregnancy with COVID‐19: A case report and literature review
Author(s) -
Wazir Sameena,
Shittu Saheed,
Dukhan Khaled,
Sharief Maram,
Beer Stephen,
Malik Waseem,
Alansari Lolwa
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5680
Subject(s) - medicine , diabetic ketoacidosis , pregnancy , diabetes mellitus , ketoacidosis , complication , covid-19 , etiology , gestational diabetes , pediatrics , intensive care medicine , pandemic , obstetrics , gestation , type 1 diabetes , endocrinology , disease , infectious disease (medical specialty) , genetics , biology
Diabetic ketoacidosis (DKA) is a life‐threatening complication of diabetes and is considered a medical emergency. Euglycemic DKA (EKDA) is a variant of DKA with a normal or minimally elevated glucose level <200 mg/dl. The condition can be difficult to diagnose due to the relatively normal glucose levels. Pregnancy, infection, and a low‐calorie intake are some of the contributing common etiologies of EDKA. Despite a rapid increase in scientific publications on COVID‐19, there are still knowledge gaps regarding the course of COVID‐19 in some patient subset. This is especially the case for pregnant women. In this case report, we discuss the course of COVID‐19 infection in a pregnant woman with gestational diabetes who developed severe euglycemic diabetic ketoacidosis triggered by various precipitating factors, including starvation, caused by COVID‐19 infection and its gastrointestinal effects.